Crewe Advisors’s QuidelOrtho QDEL Stock Holding History

Crewe Advisors’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9	Closed	-$1K	–	1207
2022 Q3	$1K	Hold	9	–	–	﹤0.01%	1184
2022 Q2	$1K	Buy	+9	New	+$918	﹤0.01%	1097

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Crewe Advisors's QDEL Position: Q4 2022 in Review

Crewe Advisors sold out of QuidelOrtho (QDEL) in Q4 2022, closing a stake of 9 shares — an estimated $1K sold.

Crewe Advisors first reported a position in QDEL in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 346 funds tracked by Wall St. Rank hold QDEL as of Q4 2022.

Crewe Advisors reported no remaining QuidelOrtho position as of Q4 2022 after selling out during the quarter.
Crewe Advisors sold 9 QuidelOrtho shares in Q4 2022, an estimated $1K.
Crewe Advisors first reported a position in QuidelOrtho in Q2 2022 and held it in 2 quarters.
Crewe Advisors's QuidelOrtho position peaked at $1K in Q3 2022.
346 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2022.

Based on Crewe Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.